Health, BI Prime, pharma, Deals, m&a,

AbbVie said that its $63 billion deal for Allergan has at least $2 billion in ‘synergies.’ That should make employees nervous.

By

AP Photo/Pablo Martinez Monsivais US drugmaker AbbVie just agreed to buy Allergan in a $63 billion mega-deal, marking a major bet that the two companies can solve their growth challenges by combining.  AbbVie said that the acquisition will result in "synergies" and other cost reductions of $2 billion or more, in areas such as research […]

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.